Boston healthcare deals involve more regulatory bodies than almost any other market in the country. The Massachusetts Determination of Need program, the Corporate Practice of Medicine framework, the Attorney General's Non-Profit Organizations Division for certain transactions, and layered licensing across specialty services all apply before the purchase agreement matters. Our managing partner handles healthcare acquisition engagements directly. Submit the transaction details if you have a qualified target.
A structured, methodical approach to healthcare m&a legal services
1
Regulatory Landscape Assessment
Independent healthcare regulatory counsel maps the state-specific regulatory path for your transaction, including CON requirements, CPOM posture, AG review triggers, and provider number transfer mechanics, before any term sheet is signed.
2
Healthcare-Focused Due Diligence
Diligence covers payor contracts, Medicare and Medicaid enrollment, Stark and AKS exposure, HIPAA posture, licensure, and compliance program maturity, with the regulatory review handled by independent healthcare regulatory counsel, to surface deal risks early.
3
Structuring and MSO Design
The deal is structured to respect CPOM limits and optimize tax and liability treatment. Where needed, independent healthcare regulatory counsel designs MSO or friendly-PC arrangements that preserve clinical independence and protect the economic deal.
4
Negotiation and Regulatory Filings
We negotiate the purchase agreement, ancillary documents, and transition services agreement while independent healthcare regulatory counsel handles CON filings, AG notifications, payor consents, and CHOW applications on a closing-driven timeline.
5
Closing and Clinical Continuity
We manage closing logistics and post-closing integration items, and independent healthcare regulatory counsel handles provider number transitions, so patient care, billing, and payor reimbursement continue without disruption.
We don't take every matter. Here is what happens when you reach out.
1
Personal Review (Within 24 Hours)
Alex reviews your transaction details. Your submission is not screened by an intake coordinator before it reaches him.
2
Fit Assessment
We evaluate whether your deal aligns with our practice. Not every matter is a fit, and we will tell you directly if it is not.
3
Initial Conversation
If there is alignment, Alex schedules a direct call to discuss your transaction, timeline, and objectives.
4
Clear Engagement Terms
Before any work begins, you receive a written engagement letter with defined scope, timeline, and fee structure. No surprises.
Request Your Boston Engagement Assessment
Acquisition Stars helps clients with healthcare acquisitions and works with independent healthcare regulatory counsel on the regulatory work. An associate supports the M&A work. We tell you who would handle your matter before any introduction, and you decide whether to proceed.
15+ years of M&A experience. Nationwide. LOI through closing.
Request Engagement Assessment
Alex reviews each inquiry. If there is alignment, you will hear back within one business day.
Submission Received
Your transaction details are under review. If there is alignment, we will be in touch.
Meanwhile, feel free to call us directly at (248) 266-2790
Frequently Asked Questions
Common questions from Boston clients
What's the Massachusetts Determination of Need program?
DoN is Massachusetts's Certificate of Need equivalent, administered by the Department of Public Health. It applies to certain facility construction projects, service expansions, and equipment acquisitions above statutory thresholds. Many ambulatory and specialty service transactions interact with DoN, and the review process can be substantial. Determining DoN applicability should happen at LOI.
How strict is Massachusetts on Corporate Practice of Medicine?
Massachusetts enforces CPOM more strictly than many states. Non-physician lay entities generally cannot own medical practices or employ physicians to practice medicine. The standard structure is an MSO arrangement where a physician-owned professional entity practices medicine and a separate management services organization provides non-clinical management services. Structural details matter, and Massachusetts-specific drafting is essential.
When does the Attorney General's office get involved in healthcare deals?
The Attorney General's Non-Profit Organizations Division reviews transactions involving Massachusetts non-profit healthcare entities to ensure that charitable assets are preserved and the transaction serves the charitable mission. Review can be substantial and may produce conditions or require deal modifications. For non-profit targets, AG review belongs in the deal timeline from LOI.
What does a healthcare acquisition attorney do?
A healthcare acquisition attorney handles the legal and regulatory side of buying or selling a healthcare business. That includes CON review, CPOM compliance, Stark and Anti-Kickback diligence, Medicare and Medicaid provider transitions, payor contract transfers, and the purchase agreement itself. Acquisition Stars works with independent healthcare regulatory counsel on the regulatory side of these transactions.
Do I need CON approval to acquire a healthcare business?
It depends on the state, the type of facility, and the scope of services. Some states require Certificate of Need approval for hospital, ASC, nursing home, or imaging transactions, while others have repealed CON entirely. The CON picture is assessed early, with independent healthcare regulatory counsel, so you know the timeline and regulatory path before signing a letter of intent.
How does Corporate Practice of Medicine (CPOM) affect the deal?
CPOM rules restrict who can own medical practices and how non-physicians can share in clinical revenue. In strong CPOM states, buyers typically use MSO or friendly-PC structures to acquire the business side of a practice while leaving clinical ownership with licensed physicians. Independent healthcare regulatory counsel we work with designs structures that hold up under state scrutiny and still deliver the economic deal you negotiated.
What happens to payor contracts and provider numbers at closing?
Payor contracts and Medicare and Medicaid provider numbers generally do not transfer automatically. Depending on structure, the buyer may need to pursue a change of ownership filing, recredentialing, or new enrollments, which affects cash flow in the months after closing. The plan for provider number continuity is built into the transaction timeline, with independent healthcare regulatory counsel handling the filings, so reimbursement does not stall.
How is Acquisition Stars different from a general M&A firm on healthcare deals?
Healthcare deals combine standard M&A risk with a second layer of regulatory risk that can sink an otherwise clean transaction. Acquisition Stars works with independent healthcare regulatory counsel on CON, CPOM, Stark and AKS, HIPAA, and payor issues alongside the commercial negotiation, with the responsiveness of a boutique firm rather than the layered staffing of a large practice.
What can I expect during an initial consultation in Boston?
During your confidential initial consultation in Boston, we'll discuss your healthcare m&a legal services needs, review your current situation, assess potential challenges specific to Massachusetts, and outline a clear path forward. We'll explain our process, answer your questions, and determine if we're the right fit for your needs.
Do you work with companies outside of Boston?
Yes, we represent clients nationwide while maintaining a strong presence in Boston. Our managing partner handles healthcare m&a legal services matters across all 50 states, coordinating with local counsel where state-specific requirements apply.
Need Specific Guidance?
Submit your transaction details for a preliminary assessment by our managing partner
Boston is the global epicenter of biotech and life sciences M&A, with Kendall Square and the Route 128 corridor housing the densest concentration of biotech companies outside San Francisco. Beyond life sciences, the region drives significant deal activity in financial technology, education technology, and defense contracting. The region's deep research university ecosystem (MIT, Harvard, Tufts) produces a steady stream of spinoff companies ripe for acquisition.
Top M&A Sectors in Boston
Biotech & Pharma
Financial Technology
Education Technology
Healthcare IT
Defense & Cybersecurity
Deal Environment
Boston's biotech-heavy deal market means acquirers often face complex IP due diligence involving university licenses, clinical trial data, and FDA regulatory considerations. Competition from large pharma strategic acquirers can push valuations higher for promising targets.
Why Acquire in Boston
Boston's concentration of world-class research institutions and highly educated workforce creates a self-reinforcing ecosystem where acquired companies can access talent, partnerships, and capital unavailable in other markets.
Massachusetts Legal Considerations
Massachusetts enacted the Noncompetition Agreement Act in 2018, limiting non-competes to 12 months and requiring garden leave pay - buyers must evaluate existing employee agreements during due diligence as many pre-2018 agreements may now be unenforceable.
Why Boston Clients Work With Us
We focus on the M&A side of biotech and life sciences transactions, understanding the unique regulatory and scientific complexities of this sector, and work with independent securities counsel on securities matters.
Boston M&A Market Insight
Massachusetts runs the Determination of Need program through the Department of Public Health, which functions as the state's Certificate of Need equivalent. DoN review applies to certain facility construction, service expansions, and equipment acquisitions above statutory thresholds. Many ambulatory and specialty service acquisitions also intersect with DoN review, and timelines for DoN can be measured in months. Massachusetts also enforces Corporate Practice of Medicine rules strongly, making MSO structuring essential for non-physician investors. For non-profit targets, the Attorney General's Non-Profit Organizations Division reviews change-of-control transactions to protect charitable assets, and that review can be substantial. Boston's academic medical centers and teaching hospital affiliations produce specialty practice deal flow with specific payor and referral dynamics, and buyers in this market run diligence at Harvard-teaching-hospital standards.
Common Deal Scenarios in Boston
1
Ambulatory Services Acquisition with DoN Review
Many Massachusetts ambulatory and specialty services acquisitions trigger Determination of Need review with the Department of Public Health. The DoN process has defined timelines, public comment periods, and substantive standards. Purchase agreements need closing conditions tied to DoN approval, with defined outside dates and walk rights on both sides if approval is delayed or denied.
2
Physician Practice Acquisition via MSO Structure
Massachusetts enforces CPOM strictly, so non-physician buyers use MSO structures. The physician-owned professional entity practices medicine; the MSO provides management services. Massachusetts regulators scrutinize MSO structures more carefully than some states, and fee-splitting and control provisions have to be drafted with attention to state-specific case law.
3
Non-Profit Healthcare Entity Acquisition with AG Review
Acquisitions involving Massachusetts non-profit healthcare entities trigger review by the Attorney General's Non-Profit Organizations Division, which examines whether the transaction preserves charitable assets and whether the transaction serves the charitable mission. AG review can produce material conditions and may require changes to deal terms.
Why Boston for M&A
Boston's healthcare M&A market is shaped by concentrated academic medical center activity, a strong regulatory framework, and deal structures that reflect Massachusetts-specific rules on DoN, CPOM, and non-profit asset protection. Buyers who plan for DoN timelines, structure MSOs with Massachusetts-specific attention, and build AG review into the deal schedule for non-profit targets close on predictable paths. Buyers who treat Boston like a lighter-regulated market get surprised.
Local Market Context
Boston M&A Market
Boston-Cambridge-Newton, MA-NH MSA · MSA population 4.9M
MSA Population (2024)
4.9M
U.S. Census Bureau
Top Industry Concentration
1 life sciences and biotechnology
2 technology and software
3 higher education and research
Boston is one of the two leading life sciences and biotechnology M&A markets in the United States, alongside the San Francisco Bay Area. The Kendall Square Cambridge corridor is among the world's densest concentrations of biotech and pharmaceutical R&D. Large pharma buyers regularly acquire Boston-area biotech companies in strategic platform acquisitions. Higher education and financial services add additional M&A dimensions to the market.
Major Boston Employers and Deal Anchors
Mass General Brigham
Pfizer (research hub)
Moderna
Biogen
Fidelity Investments
Raytheon Technologies
Transit and Logistics
Logan International Airport serves the metro with significant international connectivity. The Port of Boston handles breakbulk and specialty cargo. The MBTA regional rail serves the dense professional services workforce.
Recent Boston Deal Signal (2024-2025)
Biotech M&A in the Boston-Cambridge corridor remained highly active through 2024, with multiple large-cap pharma buyers completing acquisitions of clinical-stage companies valued between $1 billion and $10 billion. Novo Nordisk's acquisition of Cardior Pharmaceuticals and Eli Lilly's continued platform acquisitions exemplified the pattern.
Local Regulatory Notes for Healthcare M&A Legal Services
Massachusetts Securities Division is active in enforcement. Cambridge and Boston impose no unusual M&A-specific local rules, but Massachusetts has a non-compete statute that affects deal structure for talent-dependent transactions.
Massachusetts Legal Considerations for Healthcare M&A Legal Services
Non-Compete Laws
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
Filing Requirements
Entity mergers and conversions require filing with the Massachusetts Secretary of the Commonwealth, Corporations Division. The Department of Revenue requires tax waivers for asset purchases. Professional corporations require additional filings with the relevant licensing board.
Key Massachusetts Considerations
Massachusetts's Noncompetition Agreement Act requires garden leave pay (50% of highest salary in the last 2 years) during the restricted period, making non-compete retention in acquisitions expensive
The 4% millionaire surtax (effective 2023) significantly affects after-tax proceeds for high-value deal principals selling pass-through entities
Massachusetts has extensive biotech and life sciences tax incentive programs (MLSC) that can affect valuation of acquired entities with qualifying activities
Massachusetts Bar Authority
Massachusetts Bar Association. Voluntary bar. The Massachusetts Supreme Judicial Court handles attorney admission separately via the Board of Bar Overseers.
Business court: Massachusetts Superior Court Business Litigation Session (established 1999) Business Litigation Session (BLS) operates in Suffolk County (Boston); handles complex business disputes. Extended to other counties on an ad hoc basis.
Source: Massachusetts Superior Court Business Litigation Session
Massachusetts M&A Market Context
Massachusetts is a major M&A market for life sciences, biotechnology, technology, and financial services, with Boston and Cambridge generating significant deal activity.
Watchpoints
Common Boston Healthcare M&A Legal Services Pitfalls
These are the items we see derail healthcare m&a legal services transactions in the Boston market. Each one is rooted in current statutory law, recent legislative changes, or recurring patterns from the deals Alex has handled.
1
Massachusetts non-compete enforcement and earn-out exposure
State legal framework
Restricted with 12-month cap and garden leave requirement. Sale-of-business exception.
"Seller financing is a huge buzzword. Run analytics on where your inbound comes from and you'll see it. Speak publicly about seller financing and you will attract a massive amount of interest. The trouble is, the same buzzword attracts unqualified buyers. People without intent. People without funding. People without the ability or desire to actually move forward. I love the idea, and I love the possibility of a creative structure. But it's far less likely than the internet would have you believe. The unicorn opportunity that's completely seller financed, runs hands off, and flips at a massive multiple in months... that math doesn't really make sense. You see it constantly online because it works as a way to attract a large amount of interest. Just not necessarily qualified interest."
2
Boston local regulatory exposure
Local regulatory
Massachusetts Securities Division is active in enforcement. Cambridge and Boston impose no unusual M&A-specific local rules, but Massachusetts has a non-compete statute that affects deal structure for talent-dependent transactions.
3
Massachusetts regulatory framework attorneys flag at LOI
State statute
Securities regulated by Massachusetts Secretary of the Commonwealth Securities Division (sec.state.ma.us). Massachusetts has one of the more active Blue Sky enforcement environments in the U.S.; merit review authority exists for certain offerings. Non-competes are subject to Massachusetts Noncompetition Agreement Act (M.G.L. ch. 149, sec. 24L) requiring salary thresholds, garden leave pay, and prior notice.
Guides and Resources
In-depth guides to help you prepare for your transaction
Acquisition Stars helps clients with healthcare acquisitions and works with independent healthcare regulatory counsel on the regulatory work. An associate supports the M&A work. Tell us about your transaction and we will let you know if there is a fit.
